30 km south of Chennai
About 8.800 m2
About 30 m3
From 1 mm Hg to 6 Bar pressure From – 20 °C to + 270 °C
US & Indian FDA, Cofepris, ANVISA
AIS was established in 2000 in Alathur, an industrial district of Chennai, capital of the Indian southern State of Tamil Nadu, in partnership with a selected group of Indian leading entrepreneurs.
The plant started operations in 2001 and originally consisted of a single plot (A-14) of about 4,400 m² hosting a multipurpose Section 1, with about 10 m³ reactors capacity, R&D and Q.C. labs, warehouse.
In 2003 another equivalent plot of 4,400 m² (A-20) was acquired opposite to (A-14) which now hosts the fully air controlled GMP warehouse of the company.
In 2005 a fully dedicated plant for the manufacture of Clindamycin HCl (denominated Section 2) was commissioned. Total reactors capacity of this Section is about 10 m³. This Section was inspected by the US FDA in April 2008 and classified as Acceptable.
In 2005 a dedicated plant for the production of Hormones and Steroids (denominated Section 3) was commissioned. Present reactors capacity of about 4 m³, which will be increased to 6 m³ during 2009.
The following chemical reactions can be performed at Alathur: